Table 1.

World Health Organization Trial Registration Data Set describing the PANCALYZE study

Data category	Information
Primary registry and trial identifying number	German Clinical Trials Register (DRKS) http://drks-neu.uniklinik-freiburg.de/drks_web/ DRKS00006179
Date of registration in primary registry	2014/05/20
Secondary identifying numbers	-
Source(s) of monetary or material support	Department of General, Visceral and Cancer Surgery, University of Cologne, Germany Clinic for General, Visceral and Vascular Surgery, University Clinic Magdeburg, Germany Celgene GmbH, Joseph-Wild-Straße 20, 81,829 München
Primary sponsor	Department of General, Visceral and Cancer Surgery, University of Cologne, Germany Kerpener Str. 62, 50,937 Köln
Secondary sponsor(s)	-
Contact for public queries	Dr. Felix Popp Department of General, Visceral and Cancer Surgery, University of Cologne, Germany Kerpener Str. 62, 50,937 Köln pancalyze@uk-koeln.de
Contact for scientific queries	Dr. Felix Popp Department of General, Visceral and Cancer Surgery, University of Cologne, Germany Kerpener Str. 62, 50,937 Köln pancalyze@uk-koeln.de
Public title	Evaluation of molecular markers to predict the pattern of tumor recurrence and prognosis in pancreatric ductal adenocarcinoma
Scientific title	A multicenter, prospective study investigating the tumor biomarkers CXCR4, SMAD4, SOX9 and IFIT3 in patients with resected pancreatic adenocarcinoma to predict the pattern of recurrence of the disease
Countries of recruitment	Germany
Health condition(s) or problem(s) studied	C25 - Malignant neoplasm of pancreas
Intervention(s)	none
Key inclusion and exclusion criteria	inclusion criteria: patients with primary PDAC undergoing surgical resection exclusion criteria: Patient is inoperable, No tumor samples can be taken, no ductal adenocarcinoma or intraductal papillary mucinous neoplasm (IPMN) in the final histology
Study type	Non-interventional observation
Date of first enrolment	May 2014
Target sample size	450
Recruitment status	Recruiting
Primary outcome(s)	Correlation of biomarker expression and clinical course
Key secondary outcomes	none
Version	2014/05/20 Original Version 1.0